Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c; Provides Q1 & FY19 Operating Guidance

Go back to Syndax Pharmaceuticals (SNDX) Misses Q4 EPS by 3c; Provides Q1 & FY19 Operating Guidance
(NASDAQ: SNDX) Delayed: 17.62 --0 (-0%)
Previous Close $17.62    52 Week High $18.03 
Open $17.62    52 Week Low $8.97 
Day High $17.62    P/E N/A 
Day Low $17.62    EPS $0.00 
Volume 617